AI-Powered HR Tools Could Be a Game Changer for Automatic Data Processing (ADP)

  • At its annual Innovation Day earlier this week, Automatic Data Processing (ADP) unveiled new AI-powered features across its Workforce Now, ADP Global Payroll, and ADP Lyric HCM platforms, showcasing tools that address payroll errors, deliver instant analytics, and enhance compliance and employee development.
  • By integrating client feedback and drawing on extensive workforce insights, ADP’s latest AI enhancements are designed to tackle everyday HR pain points with automation, transparency, and global scalability.
  • We'll examine how ADP's new AI-driven anomaly detection could reshape the company's outlook and future growth expectations.

The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

Advertisement

Automatic Data Processing Investment Narrative Recap

To be a shareholder in Automatic Data Processing (ADP), you need to believe in continued enterprise demand for advanced, efficient, and compliant HR technology, especially as organizations look for automation to streamline complex processes. The latest AI-powered product launches add incremental value, but do not materially shift the most important near-term catalyst, which remains the successful adoption and scaling of ADP's Next Gen cloud and AI solutions across new and existing clients. The principal risk continues to be intensifying competition, which could affect market share and bookings momentum if delays persist in closing large and international deals.

Among the recent announcements, the rollout of AI-driven payroll anomaly detection is particularly relevant: it directly aligns with ADP’s push into automation and analytics, features that have the potential to enhance operational efficiency for clients. These upgrades support the ongoing shift to higher-value, AI-enabled services, the heart of ADP’s current growth catalyst, while reinforcing its platform's ability to address critical HR challenges in real-time.

Yet, against these advances, investors should also be mindful that competitive pressures may limit pricing power and delay large contract wins if...

Read the full narrative on Automatic Data Processing (it's free!)

Automatic Data Processing's outlook anticipates $24.3 billion in revenue and $5.1 billion in earnings by 2028. This scenario assumes 5.7% annual revenue growth and a $1.0 billion increase in earnings from current earnings of $4.1 billion.

Uncover how Automatic Data Processing's forecasts yield a $320.25 fair value, a 8% upside to its current price.

Exploring Other Perspectives

ADP Community Fair Values as at Sep 2025
ADP Community Fair Values as at Sep 2025

Seven fair value estimates from the Simply Wall St Community span a wide range from US$235 to US$389, capturing broad differences in investor outlook. With new AI launches aiming to accelerate adoption, your peers see several routes for ADP’s future, explore the full spectrum of perspectives now.

Explore 7 other fair value estimates on Automatic Data Processing - why the stock might be worth 21% less than the current price!

Build Your Own Automatic Data Processing Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Automatic Data Processing research is our analysis highlighting 4 key rewards that could impact your investment decision.
  • Our free Automatic Data Processing research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Automatic Data Processing's overall financial health at a glance.

Searching For A Fresh Perspective?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

  • AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.
  • Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:ADP

Automatic Data Processing

Provides cloud-based human capital management (HCM) solutions worldwide.

Solid track record with excellent balance sheet and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
46 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
66 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
22 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
CSBT.F logo
AnimalDoctorKwon on Kuros Biosciences ·

How a Mispriced Medtech Engine is Disrupting $5,000 Bone Graft Giants.

Fair Value:US$342.1892.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
RZLV logo
European_Hidden_Gem_Stocks on Rezolve AI ·

⚡ Two-Minute Drill: Rezolve AI - The AI That Doesn't Recommend Products. It Buys Them.

Fair Value:US$80.7897.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0